A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Principal Investigator: Dr. Theodore Thomas
Study Coordinator: April Kirkley
The primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol.
This study is currently enrolling. To learn more about LUNG MAP and how you can join contact our research office at (314) 289-7690.
This study is funded by the Foundation through the National Cancer Institute (NCI)
Study Coordinator: April Kirkley
The primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol.
This study is currently enrolling. To learn more about LUNG MAP and how you can join contact our research office at (314) 289-7690.
This study is funded by the Foundation through the National Cancer Institute (NCI)